Johnson & Johnson Stock in 2026: Can It Continue its 55% Rally?

2026-02-20 16:07:37

Abstract generation in progress

Johnson & Johnson (JNJ) projects a potential stock price of $288 by 2028, representing a 20% upside from its current $240, or a 7% annualized return. This valuation is based on assumptions of 6% revenue growth and 34% operating margins, with a focus on MedTech momentum and positive litigation developments. However, TIKR’s model suggests a “Sell” rating, noting that the projected 6.5% annualized return may not adequately compensate for equity risk given muted growth and ongoing litigation noise.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.